Blood Pressure in Cardiogenic Shock: It Goes Down, Not Up
No, blood pressure does not go up in cardiogenic shock—it goes down. Cardiogenic shock is fundamentally defined by hypotension (systolic blood pressure <90 mmHg) despite adequate volume status, accompanied by signs of tissue hypoperfusion 1, 2.
The Defining Hemodynamic Profile
Cardiogenic shock represents a low-output, low-pressure state where cardiac dysfunction leads to:
- Systolic blood pressure <90 mmHg for >30 minutes (or requiring vasopressors/inotropes to maintain SBP ≥90 mmHg) 1, 2, 3
- Reduced cardiac output and cardiac index (<2.2 L/min/m² without support, or cardiac power output <0.6 W) 3
- Signs of end-organ hypoperfusion: cold extremities, altered mental status, oliguria (<0.5 mL/kg/h), elevated lactate (>2 mmol/L) 1, 4
Why Blood Pressure Falls
The pathophysiology involves a vicious cycle 3, 5:
- Primary cardiac dysfunction → reduced cardiac output
- Hypotension → decreased coronary perfusion pressure
- Worsening myocardial ischemia → further contractility depression
- Progressive circulatory collapse with systemic hypoperfusion
While compensatory mechanisms attempt to maintain blood pressure through vasoconstriction (particularly angiotensin-mediated mesenteric vasoconstriction accounting for >40% of increased systemic vascular resistance 6), these mechanisms are insufficient to prevent hypotension in established cardiogenic shock.
Critical Clinical Caveat: The Pre-Shock State
Important pitfall: A patient may present with pulmonary edema and elevated blood pressure initially—this represents acute heart failure with preserved pressure, NOT cardiogenic shock 7. However, if aggressive treatment with multiple hypotensive agents (vasodilators, diuretics) is applied simultaneously, iatrogenic cardiogenic shock can develop 7. This is why monitoring is essential during acute decompensation.
The Treatment Paradox
The management goal is to increase blood pressure back toward normal through 2, 8:
- Vasopressors (norepinephrine preferred over dopamine) to maintain mean arterial pressure when needed 2, 8
- Inotropes (dobutamine, levosimendan) to increase cardiac output 2
- Mechanical circulatory support in refractory cases 2, 3
Recent evidence suggests that higher achieved mean arterial pressure (≥70 mmHg) associates with better outcomes in cardiogenic shock patients 9, 10, though excessive catecholamine dosing to achieve very high pressures may be harmful 11. The optimal balance appears to be maintaining MAP 60-90 mmHg while minimizing catecholamine burden 11.
Bottom Line
Cardiogenic shock is characterized by hypotension, not hypertension. The presence of low blood pressure (<90 mmHg systolic) combined with signs of hypoperfusion is what defines the syndrome and distinguishes it from other forms of acute heart failure where blood pressure may be normal or elevated.